Ticker Report Candriam S.C.A. purchased a new stake in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS - Free Report) during the second quarter, HoldingsChannel reports. The fund purchased 509,303 shares of the...\n more…
Zolmax Panagora Asset Management Inc. boosted its holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS - Free Report) by 8.9% in the 2nd quarter, according to the company in its most recent filing with the...\n more…
Globe Newswire WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) ( iTeos ), a clinical-stage biopharmaceutical company pioneering the discovery and...\n more…
Globe Newswire WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) ( iTeos ), a clinical-stage biopharmaceutical company pioneering the discovery and...\n more…
Ticker Report California State Teachers Retirement System lessened its holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS - Free Report) by 5.6% during the first quarter, according to its most recent disclosure...\n more…
Zolmax iTeos Therapeutics (NASDAQ:ITOS - Get Free Report) and Sorrento Therapeutics (OTCMKTS:SRNEQ - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the...\n more…